A nationwide recall has been launched for specific levothyroxine sodium tablets after the U.S. Food and Drug Administration (FDA) reported that some batches may contain less medication than expected. The affected thyroid medicine, distributed by Major Pharmaceuticals, is commonly prescribed for people with hypothyroidism and other thyroid-related conditions. The recall affects only certain lots, meaning patients are being advised to check their medication details rather than stop treatment immediately. Health officials say affected tablets may not provide the intended dose, which could influence thyroid hormone management for some patients.
FDA Identifies Specific Levothyroxine Tablets In Nationwide Recall
The FDA announced the recall after reviewing reports involving certain levothyroxine sodium tablets distributed by Major Pharmaceuticals. According to the agency, the recalled tablets were identified as subpotent, meaning they may contain a lower amount of active medication than the labeled strength. The FDA classified the action as a Class II recall, a category used when exposure to a recalled product may cause temporary or reversible health effects. The affected products were distributed in different strengths and packaging formats, including individual blister packs and cartons containing multiple blister packs. The agency’s recall notice provides details that allow consumers and healthcare providers to identify potentially affected products. The warning does not apply to every levothyroxine medication on the market, only specific lots listed in the official recall information.
How Patients Can Identify The Recalled Thyroid Medication
Consumers can determine whether their medication is included in the recall by checking the product strength, lot number, and expiration date printed on the packaging. The recalled tablets include:
Levothyroxine Sodium Tablets USP 25 mcg
- Package size: 100-tablet carton
- Lot number: N02212
- Expiration date: 07/2026
Levothyroxine Sodium Tablets USP 50 mcg
- Package size: 100-tablet carton
- Lot number: N02200
- Expiration date: 10/2026
Levothyroxine Sodium Tablets USP 75 mcg
- Package size: 100-tablet carton
- Lot numbers: N02172, N02296, N02288
- Expiration dates: 07/2026, 12/2026
Levothyroxine Sodium Tablets USP 88 mcg
- Package size: 100-tablet carton
- Lot number: N02310
- Expiration date: 01/2027
Levothyroxine Sodium Tablets USP 112 mcg
- Package size: 100-tablet carton
- Lot number: N02203
- Expiration date: 09/2026
Levothyroxine Sodium Tablets USP 125 mcg
- Package size: 100-tablet carton
- Lot number: N02266
- Expiration date: 11/2026
Levothyroxine Sodium Tablets USP 150 mcg
- Package size: 100-tablet carton
- Lot number: N02167
- Expiration date: 07/2026
10-Tablet Blister Pack Products
Levothyroxine Sodium Tablets USP 25 mcg
- Package size: 10-tablet blister pack
- Bag lot numbers: N02212A, N02212B
- Blister lot number: N02212
- Expiration date: 07/2026
Levothyroxine Sodium Tablets USP 50 mcg
- Package size: 10-tablet blister pack
- Bag lot numbers: N02200A, N02200B
- Blister lot number: N02200
- Expiration date: 10/2026
Levothyroxine Sodium Tablets USP 75 mcg
- Package size: 10-tablet blister pack
- Bag lot numbers: N02172A, N02172B, N02288A, N02288B
- Blister lot numbers: N02172, N02288
- Expiration dates: 07/2026, 12/2026
Levothyroxine Sodium Tablets USP 125 mcg
- Package size: 10-tablet blister pack
- Bag lot numbers: N02266A, N02266B
- Blister lot number: N02266
- Expiration date: 11/2026
Levothyroxine Sodium Tablets USP 150 mcg
- Package size: 10-tablet blister pack
- Bag lot number: N02167A
- Blister lot number: N02167
- Expiration date: 07/2026
Patients should carefully compare these details with the information printed on their medication packaging. The recall applies only to the specific strengths, lot numbers, and package formats listed above, not all levothyroxine products. Those who find a matching medication should contact their pharmacist or healthcare provider for advice on replacement options and ongoing thyroid treatment.
Why Levothyroxine Potency Matters For Thyroid Treatment
Levothyroxine is a synthetic form of thyroid hormone used to replace hormones that the body does not produce in sufficient amounts. Many people rely on stable dosing to maintain normal thyroid function and manage symptoms linked to hypothyroidism. A tablet with reduced potency could potentially result in patients receiving less thyroid hormone than prescribed, which may affect treatment control.
Symptoms related to insufficient thyroid hormone levels can vary and may include fatigue, sensitivity to cold, changes in weight, or other health concerns. Because thyroid treatment often requires precise dosing, patients are encouraged to speak with their doctor or pharmacist if their medication is part of the recall. Healthcare providers can recommend the appropriate next step, including whether a replacement prescription is needed.
Credit: Canva
What Patients Should Do After The Levothyroxine Recall
People who discover that they have recalled levothyroxine sodium tablets should contact their pharmacist or healthcare provider for guidance. Medical professionals can help determine whether a replacement medication should be obtained and how treatment should continue. Patients should not stop taking their thyroid medication unless instructed by a healthcare professional, as suddenly discontinuing treatment can create health risks for some individuals.
The recall serves as a reminder for prescription users to regularly review medication labels and stay informed about safety alerts affecting their treatments. For people managing thyroid conditions, maintaining consistent medical guidance remains a key part of effective care. The FDA continues to provide updated recall information as manufacturers and regulators address affected products.
